{
    "2020-07-31": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|周报】第三批集采方案下发，持续看好API板块成长性",
                "features": {
                    "keywords": [
                        "集采方案",
                        "API板块",
                        "成长性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-07-31",
                "original_text": "智通港股空仓持单统计|7月31日",
                "features": {
                    "keywords": [
                        "港股",
                        "空仓",
                        "持单"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "速读社丨康希诺科创板今日开启申购 辉瑞PDE4抑制剂在华获批",
                "features": {
                    "keywords": [
                        "康希诺",
                        "科创板",
                        "申购",
                        "辉瑞",
                        "PDE4抑制剂",
                        "获批"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "「医药速读社」康希诺科创板开启申购 优时比新药在华获批临床",
                "features": {
                    "keywords": [
                        "康希诺",
                        "科创板",
                        "申购",
                        "优时比",
                        "新药",
                        "获批临床"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "53股昨日获机构买入评级 12股上涨空间超20%",
                "features": {
                    "keywords": [
                        "机构买入评级",
                        "上涨空间"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "Q2主动偏股型基金权益配置研究：仓位提升 增持电子、医药",
                "features": {
                    "keywords": [
                        "Q2",
                        "主动偏股型基金",
                        "权益配置",
                        "仓位提升",
                        "增持",
                        "电子",
                        "医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "电子",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "兴全合宜规模腰斩后渐稳 谢治宇加仓医药减持地产",
                "features": {
                    "keywords": [
                        "兴全合宜",
                        "谢治宇",
                        "加仓医药",
                        "减持地产"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}